Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral control: the PIILR extension study.

Source:http://linkedlifedata.com/resource/pubmed/id/12461429

Download in:

View as

General Info

PMID
12461429